Iron overload in myelodysplastic syndromes: A Canadian consensus guideline

被引：40

作者：

Wells, Richard A. ^{[1
]}

Leber, Brian ^{[2
,3
]}

Buckstein, Rena ^{[1
]}

Lipton, Jeffrey H. ^{[4
]}

Hasegawa, Wanda ^{[5
]}

Grewal, Kujit ^{[6
]}

Yee, Karen ^{[4
]}

Olney, Harold J. ^{[7
]}

Larratt, Loree ^{[8
]}

Vickars, Linda ^{[9
]}

Tinmouth, Alan ^{[10
]}

机构：

[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Myelodysplast Syndromes Program, Toronto, ON M4N 3M5, Canada

[2] Hamilton Hlth Sci, Hamilton, ON, Canada

[3] McMaster Univ, Hamilton, ON, Canada

[4] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada

[5] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[6] Hlth Sci Ctr, St John, NF, Canada

[7] Hop Notre Dame de Bon Secours, CHU Montreal, Montreal, PQ H2L 4K8, Canada

[8] Univ Alberta, Edmonton, AB, Canada

[9] BC Canc Agcy, Vancouver, BC, Canada

[10] Ottawa Hosp, Ottawa, ON, Canada

来源：

LEUKEMIA RESEARCH | 2008年 / 32卷 / 09期

关键词：

myelodysplastic syndromes; iron overload; secondary hemosiderosis; iron chelation; deferoxamine; deferasirox; desferal; exjade; deferriprone; ferriprox; transfusion; prognosis; guideline;

D O I：

10.1016/j.leukres.2008.02.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In December 2005, 11 Canadian hematologists met to develop an evidence-based clinical practice guideline that would address the diagnosis, monitoring, management, and rationale for the treatment of transfusional iron overload in patients with myelodysplastic syndromes (MDS). This Expert Panel consisted of hematologists from across Canada, each with an active practice in a major population centre or a rural area. Based on an extensive literature search and years of clinical experience, their mandate was to address common clinical practice questions, particularly why treat, whom to treat, when to initiate treatment, and how to treat iron overload in patients with MDS. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：1338 / 1353

页数：16

共 50 条

[1] Consensus statement on iron overload in myelodysplastic syndromes
Bennett, John M.
AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (11) : 858 - 861
[2] Iron overload in myelodysplastic syndromes
Mahesh, Sameer
Ginzburg, Yelena
Verma, Amit
LEUKEMIA & LYMPHOMA, 2008, 49 (03) : 427 - 438
[3] Iron overload in myelodysplastic syndromes
Chodirker, Lisa
Wells, Richard A.
EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (03) : 215 - 218
[4] Iron overload and myelodysplastic syndromes
Calvet, Laure
HEMATOLOGIE, 2010, 16 : 21 - 24
[5] Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement
Bor-Sheng Ko
Cheng-Shyong Chang
Ming-Chih Chang
Tsai Yun Chen
Tzeon-Jye Chiou
Chang-Fang Chiu
Wen-Li Huang
Woei-Yau Kao
Yii-Jenq Lan
Shen-Fung Lin
Tran-Der Tan
Jih-Luh Tang
Cheng-Hwai Tzeng
Po-Nan Wang
Su-Pen Yet
Hwei-Fang Tien
International Journal of Hematology, 2014, 100 : 7 - 15
[6] Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement
Ko, Bor-Sheng
Chang, Cheng-Shyong
Chang, Ming-Chih
Chen, Tsai Yun
Chiou, Tzeon-Jye
Chiu, Chang-Fang
Huang, Wen-Li
Kao, Woei-Yau
Lan, Yii-Jenq
Lin, Shen-Fung
Tan, Tran-Der
Tang, Jih-Luh
Tzeng, Cheng-Hwai
Wang, Po-Nan
Yet, Su-Pen
Tien, Hwei-Fang
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (01) : 7 - 15
[7] Myelodysplastic syndromes and the role of iron overload
Harvey, R. Donald
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (07) : S3 - S9
[8] Iron overload in myelodysplastic syndromes Introduction
Harvey, R. Donald
Fausel, Christopher A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (07) : S2 - S2
[9] Iron overload in patients with myelodysplastic syndromes
Jensen P.-D.
Current Hematologic Malignancy Reports, 2007, 2 (1) : 13 - 21
[10] Iron overload in myelodysplastic syndromes (MDS)
Gattermann, Norbert
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (01) : 55 - 63

← 1 2 3 4 5 →